|
|
| Vitamines - Compléments Alimentaires > Etude de marché sectorielle |
| OTC Healthcare in Norway to 2010 |
|
|
|
|
€ 396,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Février 2007 |
Taille du document : |
159 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Nutraceuticals in the United Kingdom 18 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry. It includes data on market size an |
160,00 €
|
| |
| |
Healthcare Opportunities for Food Ingredient Manufacturers 0 pages | Janvier 2007 |
For food ingredient companies willing to enter the non-food market, there is over a billion dollars of market potential awaiting them. In addition to increasing the profitability of their tradition |
2 396,00 €
|
| |
| |
Functional Foods and Drinks 757 pages | Juin 2006 |
This report analyzes the worldwide markets for Functional Foods and Drinks in US$ Million. The major product segments analyzed are Cereals and Grains, Beverages, Dairy Products, and Snacks. The |
3 160,00 €
|
| |
| |
Sales of Vitamin E Supplements in the U.S., 1995-2003 1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
US Vitamins & Minerals 2004 13 pages | Novembre 2004 |
Snapdata's US Vitamins & Minerals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US vitamin and mineral mar |
240,00 €
|
| |
| |
Global market review of diet trends and weight management – forecasts to 2012 96 pages | Septembre 2006 |
Global market review of diet trends and weight management – forecasts to 2012This exclusive report from just-food provides insight into the developing and controversial industry of dieting and weight |
767,00 €
|
| |
| |
Vitamins and Supplements 180 pages | Novembre 2006 |
The vitamins, minerals and supplements (VMS) market grew by only 0.9% in value in the 12 months ending August 2006. This followed stronger growth in calendar years 2003 and 2004. Prior to that, |
1 260,00 €
|
| |
| |
Nutraceuticals 897 pages | Janvier 2006 |
This report analyzes the worldwide markets for Nutraceuticals in Millions of US$. The specific product segments analyzed are Dietary Supplements, and Functional Foods. The sub product segments a |
3 091,00 €
|
| |
| |
OTC Vitamins and Dietary Supplements in France 10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in France' Major Market Profile report offers an introduction to the market. It is c. 10 pages long and provides a top line ove |
198,00 €
|
| |
| |
State Market Index: Dietary supplements, dairy and non-dairy based - Manufacturing 12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Dietary supplements, dairy and non-dairy based [Manufacturing sector], broken out on a state-by-state basis. Analysis is based on data applied |
475,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Healthcare in Norway to 2010 |
|
|
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Norway. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2005 and full forecasts to 2010.
Scope
Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products.Provides market value, volume, expenditure and consumption data by market, segment and subsegment.Includes company and brand share data by category, as well as distribution channel data.Contains market value segmentation by demographic and socioeconomic group.
Highlights
The market for OTC Healthcare in Norway increased between 2000-2005, growing at an average annual rate of 2.9%.
The leading company in the market in 2005 was Pfizer Inc. The second-largest player was Novartis AG with GlaxoSmithKline Plc in third place.
Reasons to Purchase
Discover the major quantitative trends affecting the OTC Healthcare markets.Understand consumers' consumption and expenditure patterns.Understand the future direction of the market with reliable historical data and full five year forecasting.
|
|
TABLE OF CONTENTS ABOUT DATAMONITOR 2 TABLE OF CONTENTS 3 LIST OF TABLES 7 LIST OF FIGURES 18 CHAPTER 1 INTRODUCTION 20 What is this report about? 20 How to use this report 20 Definitions 20 CHAPTER 2 NORWAY OTC HEALTHCARE 25 2.1 Value 25 2.2 Market Share 33 2.3 Distribution 37 2.4 Expenditure & consumption per head 38 2.5 ConsumerGraphics 42 CHAPTER 3 NORWAY ANALGESICS 45 3.1 Value 45 3.2 Market Share 50 3.3 Distribution 52 3.4 Expenditure & consumption per head 53 3.5 ConsumerGraphics 55 CHAPTER 4 NORWAY COUGH AND COLD PREPARATIONS 58 4.1 Value 58 4.2 Market Share 64 4.3 Distribution 66 4.4 Expenditure & consumption per head 67 4.5 ConsumerGraphics 70 CHAPTER 5 NORWAY INDIGESTION PREPARATIONS 73 5.1 Value 73 5.2 Market Share 78 5.3 Distribution 80 5.4 Expenditure & consumption per head 81 5.5 ConsumerGraphics 83 CHAPTER 6 NORWAY MEDICATED SKIN PRODUCTS 86 6.1 Value 86 6.2 Market Share 92 6.3 Distribution 94 6.4 Expenditure & consumption per head 95 6.5 ConsumerGraphics 98 CHAPTER 7 NORWAY TRADITIONAL MEDICINES 101 7.1 Value 101 7.2 Market Share 105 7.3 Distribution 107 7.4 Expenditure & consumption per head 108 7.5 ConsumerGraphics 110 CHAPTER 8 NORWAY VITAMINS AND MINERALS 113 8.1 Value 113 8.2 Market Share 119 8.3 Distribution 121 8.4 Expenditure & consumption per head 122 8.5 ConsumerGraphics 124 CHAPTER 9 NORWAY OTHER OTC HEALTHCARE 127 9.1 Value 127 9.2 Market Share 133 9.3 Distribution 136 9.4 Expenditure & consumption per head 137 9.5 ConsumerGraphics 140 CHAPTER 10 NORWAY SOCIOECONOMIC PROFILE 143 10.1 Country Overview 143 10.2 Key Facts 144 10.3 Political Overview 146 10.4 Norway Economic Overview 147 CHAPTER 11 NORWAY MACROECONOMIC PROFILE 148 11.1 Macroeconomic Indicators 148 CHAPTER 12 RESEARCH METHODOLOGY 154 12.1 Methodology overview 154 12.2 Secondary research 155 12.3 Market modelling 156 12.4 Primary research 157 12.5 Data finalisation 158 12.6 Ongoing research 158 CHAPTER 13 APPENDIX 159 13.1 Future readings 159 13.2 How to contact experts in your industry 159 LIST OF TABLES Table 1: OTC Healthcare category definitions 21 Table 2: OTC Healthcare distribution channels 23 Table 3: Norway OTC Healthcare value, 2000-2005 (NOK m, 2005 prices) 25 Table 4: Norway OTC Healthcare value forecast, 2005-2010 (NOK m, 2005 prices) 26 Table 5: Norway OTC Healthcare value, 2000-2005 (NOK m, nominal prices) 28 Table 6: Norway OTC Healthcare value forecast, 2005-2010 (NOK m, nominal prices) 29 Table 7: Norway OTC Healthcare value, 2000-2005 (US$ m nominal prices) 30 Table 8: Norway OTC Healthcare value forecast, 2005-2010 (US$ m nominal prices) 31 Table 9: Norway OTC Healthcare brand share, by value, 2004-2005 (%) 33 Table 10: Norway OTC Healthcare value, by brand, 2004-2005 (NOK m nominal prices) 34 Table 11: Norway OTC Healthcare company share, by value, 2004-2005 (%) 35 Table 12: Norway OTC Healthcare value, by company, 2004-2005 (NOK m nominal prices) 36 Table 13: Norway OTC Healthcare distribution channels, by value, 2004-2005 (%) 37 Table 14: Norway OTC Healthcare value, by distribution channel, 2004-2005 (NOK m nominal prices) 37 Table 15: Norway OTC Healthcare expenditure per head, 2000-2005 (NOK, 2005 prices) 38 Table 16: Norway OTC Healthcare forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 39 Table 17: Norway OTC Healthcare expenditure per head, 2000-2005 (US$ nominal prices) 40 Table 18: Norway OTC Healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 41 Table 19: Norway OTC Healthcare value, by age group, 2005 42 Table 20: Norway OTC Healthcare value, by income group, 2005 42 Table 21: Norway OTC Healthcare value, by gender, 2005 43 Table 22: Norway OTC Healthcare value, by marital status, 2005 43 Table 23: Norway OTC Healthcare value, by size of household, 2005 43 Table 24: Norway OTC Healthcare value, by urban/rural residence, 2005 44 Table 25: Norway Analgesics value, 2000-2005 (NOK m, 2005 prices) 45 Table 26: Norway Analgesics value forecast, 2005-2010 (NOK m, 2005 prices) 45 Table 27: Norway Analgesics value, 2000-2005 (NOK m, nominal prices) 47 Table 28: Norway Analgesics value forecast, 2005-2010 (NOK m, nominal prices) 47 Table 29: Norway Analgesics value, 2000-2005 (US$ m nominal prices) 48 Table 30: Norway Analgesics value forecast, 2005-2010 (US$ m nominal prices) 48 Table 31: Norway Analgesics brand share, by value, 2004-2005 (%) 50 Table 32: Norway Analgesics value, by brand, 2004-2005 (NOK m nominal prices) 50 Table 33: Norway Analgesics company share, by value, 2004-2005 (%) 51 Table 34: Norway Analgesics value, by company, 2004-2005 (NOK m nominal prices) 51 Table 35: Norway Analgesics distribution channels, by value, 2004-2005 (%) 52 Table 36: Norway Analgesics value, by distribution channel, 2004-2005 (NOK m nominal prices) 52 Table 37: Norway Analgesics expenditure per head, 2000-2005 (NOK, 2005 prices) 53 Table 38: Norway Analgesics forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 53 Table 39: Norway Analgesics expenditure per head, 2000-2005 (US$ nominal prices) 54 Table 40: Norway Analgesics forecast expenditure per head, 2005-2010 (US$ nominal prices) 54 Table 41: Norway Analgesics value, by age group, 2005 55 Table 42: Norway Analgesics value, by income group, 2005 55 Table 43: Norway Analgesics value, by gender, 2005 56 Table 44: Norway Analgesics value, by marital status, 2005 56 Table 45: Norway Analgesics value, by size of household, 2005 56 Table 46: Norway Analgesics value, by urban/rural residence, 2005 57 Table 47: Norway Cough and cold preparations value, 2000-2005 (NOK m, 2005 prices) 58 Table 48: Norway Cough and cold preparations value forecast, 2005-2010 (NOK m, 2005 prices) 59 Table 49: Norway Cough and cold preparations value, 2000-2005 (NOK m, nominal prices) 61 Table 50: Norway Cough and cold preparations value forecast, 2005-2010 (NOK m, nominal prices) 61 Table 51: Norway Cough and cold preparations value, 2000-2005 (US$ m nominal prices) 62 Table 52: Norway Cough and cold preparations value forecast, 2005-2010 (US$ m nominal prices) 62 Table 53: Norway Cough and cold preparations brand share, by value, 2004-2005 (%) 64 Table 54: Norway Cough and cold preparations value, by brand, 2004-2005 (NOK m nominal prices) 64 Table 55: Norway Cough and cold preparations company share, by value, 2004-2005 (%) 65 Table 56: Norway Cough and cold preparations value, by company, 2004-2005 (NOK m nominal prices) 65 Table 57: Norway Cough and cold preparations distribution channels, by value, 2004-2005 (%) 66 Table 58: Norway Cough and cold preparations value, by distribution channel, 2004-2005 (NOK m nominal prices) 66 Table 59: Norway Cough and cold preparations expenditure per head, 2000-2005 (NOK, 2005 prices) 67 Table 60: Norway Cough and cold preparations forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 68 Table 61: Norway Cough and cold preparations expenditure per head, 2000-2005 (US$ nominal prices) 69 Table 62: Norway Cough and cold preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 69 Table 63: Norway Cough and cold preparations value, by age group, 2005 70 Table 64: Norway Cough and cold preparations value, by income group, 2005 70 Table 65: Norway Cough and cold preparations value, by gender, 2005 71 Table 66: Norway Cough and cold preparations value, by marital status, 2005 71 Table 67: Norway Cough and cold preparations value, by size of household, 2005 71 Table 68: Norway Cough and cold preparations value, by urban/rural residence, 2005 72 Table 69: Norway Indigestion preparations value, 2000-2005 (NOK m, 2005 prices) 73 Table 70: Norway Indigestion preparations value forecast, 2005-2010 (NOK m, 2005 prices) 73 Table 71: Norway Indigestion preparations value, 2000-2005 (NOK m, nominal prices) 75 Table 72: Norway Indigestion preparations value forecast, 2005-2010 (NOK m, nominal prices) 75 Table 73: Norway Indigestion preparations value, 2000-2005 (US$ m nominal prices) 76 Table 74: Norway Indigestion preparations value forecast, 2005-2010 (US$ m nominal prices) 76 Table 75: Norway Indigestion preparations brand share, by value, 2004-2005 (%) 78 Table 76: Norway Indigestion preparations value, by brand, 2004-2005 (NOK m nominal prices) 78 Table 77: Norway Indigestion preparations company share, by value, 2004-2005 (%) 79 Table 78: Norway Indigestion preparations value, by company, 2004-2005 (NOK m nominal prices) 79 Table 79: Norway Indigestion preparations distribution channels, by value, 2004-2005 (%) 80 Table 80: Norway Indigestion preparations value, by distribution channel, 2004-2005 (NOK m nominal prices) 80 Table 81: Norway Indigestion preparations expenditure per head, 2000-2005 (NOK, 2005 prices) 81 Table 82: Norway Indigestion preparations forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 81 Table 83: Norway Indigestion preparations expenditure per head, 2000-2005 (US$ nominal prices) 82 Table 84: Norway Indigestion preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 82 Table 85: Norway Indigestion preparations value, by age group, 2005 83 Table 86: Norway Indigestion preparations value, by income group, 2005 83 Table 87: Norway Indigestion preparations value, by gender, 2005 84 Table 88: Norway Indigestion preparations value, by marital status, 2005 84 Table 89: Norway Indigestion preparations value, by size of household, 2005 84 Table 90: Norway Indigestion preparations value, by urban/rural residence, 2005 85 Table 91: Norway Medicated skin products value, 2000-2005 (NOK m, 2005 prices) 86 Table 92: Norway Medicated skin products value forecast, 2005-2010 (NOK m, 2005 prices) 87 Table 93: Norway Medicated skin products value, 2000-2005 (NOK m, nominal prices) 89 Table 94: Norway Medicated skin products value forecast, 2005-2010 (NOK m, nominal prices) 89 Table 95: Norway Medicated skin products value, 2000-2005 (US$ m nominal prices) 90 Table 96: Norway Medicated skin products value forecast, 2005-2010 (US$ m nominal prices) 90 Table 97: Norway Medicated skin products brand share, by value, 2004-2005 (%) 92 Table 98: Norway Medicated skin products value, by brand, 2004-2005 (NOK m nominal prices) 92 Table 99: Norway Medicated skin products company share, by value, 2004-2005 (%) 93 Table 100: Norway Medicated skin products value, by company, 2004-2005 (NOK m nominal prices) 93 Table 101: Norway Medicated skin products distribution channels, by value, 2004-2005 (%) 94 Table 102: Norway Medicated skin products value, by distribution channel, 2004-2005 (NOK m nominal prices) 94 Table 103: Norway Medicated skin products expenditure per head, 2000-2005 (NOK, 2005 prices) 95 Table 104: Norway Medicated skin products forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 96 Table 105: Norway Medicated skin products expenditure per head, 2000-2005 (US$ nominal prices) 97 Table 106: Norway Medicated skin products forecast expenditure per head, 2005-2010 (US$ nominal prices) 97 Table 107: Norway Medicated skin products value, by age group, 2005 98 Table 108: Norway Medicated skin products value, by income group, 2005 98 Table 109: Norway Medicated skin products value, by gender, 2005 99 Table 110: Norway Medicated skin products value, by marital status, 2005 99 Table 111: Norway Medicated skin products value, by size of household, 2005 99 Table 112: Norway Medicated skin products value, by urban/rural residence, 2005 100 Table 113: Norway Traditional medicines value, 2000-2005 (NOK m, 2005 prices) 101 Table 114: Norway Traditional medicines value forecast, 2005-2010 (NOK m, 2005 prices) 101 Table 115: Norway Traditional medicines value, 2000-2005 (NOK m, nominal prices) 103 Table 116: Norway Traditional medicines value forecast, 2005-2010 (NOK m, nominal prices) 103 Table 117: Norway Traditional medicines value, 2000-2005 (US$ m nominal prices) 104 Table 118: Norway Traditional medicines value forecast, 2005-2010 (US$ m nominal prices) 104 Table 119: Norway Traditional medicines brand share, by value, 2004-2005 (%) 105 Table 120: Norway Traditional medicines value, by brand, 2004-2005 (NOK m nominal prices) 105 Table 121: Norway Traditional medicines company share, by value, 2004-2005 (%) 106 Table 122: Norway Traditional medicines value, by company, 2004-2005 (NOK m nominal prices) 106 Table 123: Norway Traditional medicines distribution channels, by value, 2004-2005 (%) 107 Table 124: Norway Traditional medicines value, by distribution channel, 2004-2005 (NOK m nominal price) 107 Table 125: Norway Traditional medicines expenditure per head, 2000-2005 (NOK, 2005 prices) 108 Table 126: Norway Traditional medicines forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 108 Table 127: Norway Traditional medicines expenditure per head, 2000-2005 (US$ nominal prices) 109 Table 128: Norway Traditional medicines forecast expenditure per head, 2005-2010 (US$ nominal prices) 109 Table 129: Norway Traditional medicines value, by age group, 2005 110 Table 130: Norway Traditional medicines value, by income group, 2005 110 Table 131: Norway Traditional medicines value, by gender, 2005 111 Table 132: Norway Traditional medicines value, by marital status, 2005 111 Table 133: Norway Traditional medicines value, by size of household, 2005 111 Table 134: Norway Traditional medicines value, by urban/rural residence, 2005 112 Table 135: Norway Vitamins and minerals value, 2000-2005 (NOK m, 2005 prices) 113 Table 136: Norway Vitamins and minerals value forecast, 2005-2010 (NOK m, 2005 prices) 114 Table 137: Norway Vitamins and minerals value, 2000-2005 (NOK m, nominal prices) 116 Table 138: Norway Vitamins and minerals value forecast, 2005-2010 (NOK m, nominal prices) 116 Table 139: Norway Vitamins and minerals value, 2000-2005 (US$ m nominal prices) 117 Table 140: Norway Vitamins and minerals value forecast, 2005-2010 (US$ m nominal prices) 117 Table 141: Norway Vitamins and minerals brand share, by value, 2004-2005 (%) 119 Table 142: Norway Vitamins and minerals value, by brand, 2004-2005 (NOK m nominal prices) 119 Table 143: Norway Vitamins and minerals company share, by value, 2004-2005 (%) 120 Table 144: Norway Vitamins and minerals value, by company, 2004-2005 (NOK m nominal prices) 120 Table 145: Norway Vitamins and minerals distribution channels, by value, 2004-2005 (%) 121 Table 146: Norway Vitamins and minerals value, by distribution channel, 2004-2005 (NOK m nominal price) 121 Table 147: Norway Vitamins and minerals expenditure per head, 2000-2005 (NOK, 2005 prices) 122 Table 148: Norway Vitamins and minerals forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 122 Table 149: Norway Vitamins and minerals expenditure per head, 2000-2005 (US$ nominal prices) 123 Table 150: Norway Vitamins and minerals forecast expenditure per head, 2005-2010 (US$ nominal prices) 123 Table 151: Norway Vitamins and minerals value, by age group, 2005 124 Table 152: Norway Vitamins and minerals value, by income group, 2005 124 Table 153: Norway Vitamins and minerals value, by gender, 2005 125 Table 154: Norway Vitamins and minerals value, by marital status, 2005 125 Table 155: Norway Vitamins and minerals value, by size of household, 2005 125 Table 156: Norway Vitamins and minerals value, by urban/rural residence, 2005 126 Table 157: Norway Other OTC healthcare value, 2000-2005 (NOK m, 2005 prices) 127 Table 158: Norway Other OTC healthcare value forecast, 2005-2010 (NOK m, 2005 prices) 128 Table 159: Norway Other OTC healthcare value, 2000-2005 (NOK m, nominal prices) 130 Table 160: Norway Other OTC healthcare value forecast, 2005-2010 (NOK m, nominal prices) 130 Table 161: Norway Other OTC healthcare value, 2000-2005 (US$ m nominal prices) 131 Table 162: Norway Other OTC healthcare value forecast, 2005-2010 (US$ m nominal prices) 131 Table 163: Norway Other OTC healthcare brand share, by value, 2004-2005 (%) 133 Table 164: Norway Other OTC healthcare value, by brand, 2004-2005 (NOK m nominal prices) 134 Table 165: Norway Other OTC healthcare company share, by value, 2004-2005 (%) 135 Table 166: Norway Other OTC healthcare value, by company, 2004-2005 (NOK m nominal prices) 135 Table 167: Norway Other OTC healthcare distribution channels, by value, 2004-2005 (%) 136 Table 168: Norway Other OTC healthcare value, by distribution channel, 2004-2005 (NOK m nominal prices) 136 Table 169: Norway Other OTC healthcare expenditure per head, 2000-2005 (NOK, 2005 prices) 137 Table 170: Norway Other OTC healthcare forecast expenditure per head, 2005-2010 (NOK, 2005 prices) 138 Table 171: Norway Other OTC healthcare expenditure per head, 2000-2005 (US$ nominal prices) 139 Table 172: Norway Other OTC healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 139 Table 173: Norway Other OTC healthcare value, by age group, 2005 140 Table 174: Norway Other OTC healthcare value, by income group, 2005 140 Table 175: Norway Other OTC healthcare value, by gender, 2005 141 Table 176: Norway Other OTC healthcare value, by marital status, 2005 141 Table 177: Norway Other OTC healthcare value, by size of household, 2005 141 Table 178: Norway Other OTC healthcare value, by urban/rural residence, 2005 142 Table 179: Norway Key Facts 144 Table 180: Norway population, by age group, 2000-2005 (millions) 148 Table 181: Norway population forecast, by age group, 2005-2010 (millions) 149 Table 182: Norway population, by gender, 2000-2005 (millions) 149 Table 183: Norway population forecast, by gender, 2005-2010 (millions) 150 Table 184: Norway real GDP, 2000-2005 (NOK bn, 2005 prices) 150 Table 185: Norway real GDP forecast, 2005-2010 (NOK bn, 2005 prices) 150 Table 186: Norway nominal GDP, 2000-2005 (NOK bn, nominal prices) 151 Table 187: Norway nominal GDP forecast, 2005-2010 (NOK bn, nominal prices) 151 Table 188: Norway real GDP, 2000-2005 (US$ bn, 2005 prices) 151 Table 189: Norway real GDP forecast, 2005-2010 (US$ bn, 2005 prices) 152 Table 190: Norway consumer price index, 2000-2005 (2000=100) 152 Table 191: Norway consumer price index, 2005-2010 (2000=100) 152 Table 192: Norway exchange rate, 2000-2005 153
LIST OF FIGURES Figure 1: Norway OTC Healthcare value & value forecast, 2000-2010 (NOK m, 2005 prices) 27 Figure 2: Norway OTC Healthcare category growth comparison, by value, 2000-2010 32 Figure 3: Norway Analgesics value & value forecast, 2000-2010 (NOK m, 2005 prices) 46 Figure 4: Norway Analgesics segment growth comparison, by value, 2000-2010 49 Figure 5: Norway Cough and cold preparations value & value forecast, 2000-2010 (NOK m, 2005 prices) 60 Figure 6: Norway Cough and cold preparations segment growth comparison, by value, 2000-2010 63 Figure 7: Norway Indigestion preparations value & value forecast, 2000-2010 (NOK m, 2005 prices) 74 Figure 8: Norway Indigestion preparations segment growth comparison, by value, 2000-2010 77 Figure 9: Norway Medicated skin products value & value forecast, 2000-2010 (NOK m, 2005 prices) 88 Figure 10: Norway Medicated skin products segment growth comparison, by value, 2000-2010 91 Figure 11: Norway Traditional medicines value & value forecast, 2000-2010 (NOK m, 2005 prices) 102 Figure 12: Norway Vitamins and minerals value & value forecast, 2000-2010 (NOK m, 2005 prices) 115 Figure 13: Norway Vitamins and minerals segment growth comparison, by value, 2000-2010 118 Figure 14: Norway Other OTC healthcare value & value forecast, 2000-2010 (NOK m, 2005 prices) 129 Figure 15: Norway Other OTC healthcare segment growth comparison, by value, 2000-2010 132 Figure 16: Map of Norway 145 Figure 17: Annual data review process 155
|
|
|
PPLSEN
|
|
|
|
|